NASDAQ:CBLL CeriBell Q3 2026 Earnings Date & Estimates $23.15 -0.33 (-1.41%) Closing price 04:00 PM EasternExtended Trading$23.18 +0.04 (+0.15%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. CeriBell is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 3, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from CeriBell in Q3 2026CeriBell is expected to post earnings of -$0.50 per share on revenue of $29.17 million. In the same quarter a year earlier CeriBell reported -$0.37 per share on revenue of $22.59 million. CeriBell last reported on August 10, 2026, posting -$0.51 per share and missing the -$0.47 consensus estimate. CeriBell has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.50Expected Revenue$29.17 millionPrior-Year EPS-$0.37Prior-Year Revenue$22.59 millionExpected Revenue Growth+29.1%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.51 (Missed by -$0.04)Last Quarter Revenue$28.10 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report CeriBell Q3 2026 Earnings FAQ When does CeriBell report Q3 2026 earnings? CeriBell (NASDAQ:CBLL) is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. What time is CeriBell's Q3 2026 earnings call? CeriBell's Q3 2026 earnings conference call is scheduled for Tuesday, November 3, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for CeriBell? Analysts expect CeriBell to post earnings of -$0.50 per share for Q3 2026. How much revenue is CeriBell expected to report? The consensus revenue estimate for CeriBell is $29.17 million for Q3 2026. CeriBell Earnings HeadlinesComparing CeriBell (NASDAQ:CBLL) and Becton, Dickinson and Company (NYSE:BDX)October 4, 2026 | americanbankingnews.comCeriBell (NASDAQ:CBLL) Stock Gets Price Target Bump from TD CowenOctober 4, 2026 | americanbankingnews.comThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.October 8 at 1:00 AM | Golden Portfolio (Ad)CeriBell (NASDAQ:CBLL) CTO Raymond Woo Sells 4,887 Shares of Company StockOctober 3, 2026 | americanbankingnews.comCeriBell: FDA Clearances And Delirium Expansion Could Create A New Growth DriverOctober 1, 2026 | seekingalpha.comCeriBell Receives FDA Clearance for Platform Software UpdateSeptember 30, 2026 | finance.yahoo.comSee More CeriBell Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like CeriBell? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CeriBell and other key companies, straight to your email. Email Address About CeriBellCeriBell (NASDAQ:CBLL) develops medical technology designed to make electroencephalography (EEG) more accessible in acute-care settings. Its primary product is the Ceribell Rapid Response EEG system, a portable, point-of-care platform that enables clinicians to record and assess brain activity at the bedside, including when evaluating patients for seizures and status epilepticus. The Ceribell system combines a simplified EEG headband and recording device with software that supports rapid interpretation. The platform also incorporates artificial-intelligence-based seizure detection tools intended to help healthcare professionals identify abnormal brain activity and make more timely clinical decisions. Founded in 2015, CeriBell serves hospitals and other healthcare providers, with a focus on emergency departments, intensive care units and other settings where conventional EEG testing may not be immediately available. The company is headquartered in Sunnyvale, California, and markets its products primarily in the United States.View CeriBell ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Levi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueSkydance Just Became a Media Giant—With an $80 Billion Debt LoadConstellation Brands Beat Earnings, But Beer Demand Is Still a ProblemTesla's EV Delivery Beat Is In, So What Happens Now?BigBear.ai Is Heavily Shorted—and Its Fundamentals Are Starting to ChangePenguin Solutions Is Soaring as AI Memory Demand Explodes Upcoming Earnings Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
